Hennion & Walsh Asset Management, Inc.

Position in FLGT — Fulgent Genetics, Inc.

CIK 1861642 Parsippany, NJ

Position in FLGT

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$2,286,030

+$950,271 QoQ

Shares Held

111,405

+32.6% QoQ

Ownership

0.392%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

of 10 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Hennion & Walsh Asset Management, Inc. holds $9,011,750 across 5 Diagnostics & Research names. FLGT ranks #2 (25.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	5,549	$2,782,046
2	FLGT	Fulgent Genetics, Inc. This page	111,405	$2,286,030
3	DHR	Danaher Corp /De/	9,837	$1,873,751
4	DGX	Quest Diagnostics Inc	7,712	$1,634,558
5	IDXX	Idexx Laboratories Inc /De	827	$435,365

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,286,030	111,405	+32.6%	Shares	Sole	2026-07-08
2026-03-31	$1,335,759	84,010	+26.9%	Shares	Sole	2026-05-13
2025-12-31	$1,738,811	66,190	—	Shares	Sole	2026-01-14
No filing history on record for this holder in this stock.